101 related articles for article (PubMed ID: 8773934)
1. Intravitreal delivery of ciprofloxacin.
Hainsworth DP; Conklin JD; Bierly JR; Ax D; Ashton P
J Ocul Pharmacol Ther; 1996; 12(2):183-91. PubMed ID: 8773934
[TBL] [Abstract][Full Text] [Related]
2. Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery.
Cardillo JA; Paganelli F; Melo LA; Silva AA; Pizzolitto AC; Oliveira AG;
Arch Ophthalmol; 2010 Jan; 128(1):81-7. PubMed ID: 20065222
[TBL] [Abstract][Full Text] [Related]
3. Penetration of topical and oral ciprofloxacin into the aqueous and vitreous humor in inflamed eyes.
Oztürk F; Kortunay S; Kurt E; Ilker SS; Basci NE; Bozkurt A
Retina; 1999; 19(3):218-22. PubMed ID: 10380027
[TBL] [Abstract][Full Text] [Related]
4. Ocular bioavailability of ciprofloxacin in sustained release formulations.
Ke TL; Cagle G; Schlech B; Lorenzetti OJ; Mattern J
J Ocul Pharmacol Ther; 2001 Dec; 17(6):555-63. PubMed ID: 11777179
[TBL] [Abstract][Full Text] [Related]
5. A new vitreal drug delivery system using an implantable biodegradable polymeric device.
Kimura H; Ogura Y; Hashizoe M; Nishiwaki H; Honda Y; Ikada Y
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2815-9. PubMed ID: 8188476
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of ciprofloxacin and dexamethasone in experimental pseudomonas endophthalmitis.
Kim IT; Chung KH; Koo BS
Korean J Ophthalmol; 1996 Jun; 10(1):8-17. PubMed ID: 8755196
[TBL] [Abstract][Full Text] [Related]
7. [A pharmacodynamics study of an intravitreal amphotericin B drug delivery system for the treatment of experimental Aspergillus fumigatus endophthalmitis].
Yang X; Dong XG; Liu AM; Sun SY; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2007 Jun; 43(6):546-53. PubMed ID: 17897534
[TBL] [Abstract][Full Text] [Related]
8. Preparation of polylactic acid microcapsules containing ciprofloxacin.
Yu WP; Wong JP; Chang TM
J Microencapsul; 1998; 15(4):515-23. PubMed ID: 9651872
[TBL] [Abstract][Full Text] [Related]
9. The effects of prolonged acute use and inflammation on the ocular penetration of topical ciprofloxacin.
Oztürk F; Kurt E; Inan UU; Kortunay S; Ilker SS; Başci NE; Bozkurt A
Int J Pharm; 2000 Aug; 204(1-2):97-100. PubMed ID: 11011991
[TBL] [Abstract][Full Text] [Related]
10. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide implant.
Koort JK; Makinen TJ; Suokas E; Veiranto M; Jalava J; Tormala P; Aro HT
Acta Orthop; 2008 Apr; 79(2):295-301. PubMed ID: 18484258
[TBL] [Abstract][Full Text] [Related]
11. Transcorneal iontophoresis for delivery of ciprofloxacin hydrochloride.
Vaka SR; Sammeta SM; Day LB; Murthy SN
Curr Eye Res; 2008 Aug; 33(8):661-7. PubMed ID: 18696341
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic delivery of ciprofloxacin hydrochloride from different polymer formulations: in vitro and in vivo studies.
Charoo NA; Kohli K; Ali A; Anwer A
Drug Dev Ind Pharm; 2003 Feb; 29(2):215-21. PubMed ID: 12648018
[TBL] [Abstract][Full Text] [Related]
13. In vitro release of new quinolones from biodegradable systems: a comparative study.
Andreopoulos AG; Korakis T; Dounis E; Anastasiadis A; Tzivelekis P; Kanellakopoulou K
J Biomater Appl; 1996 Apr; 10(4):338-47. PubMed ID: 8859405
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis.
Saleh M; Lefèvre S; Acar N; Bourcier T; Marcellin L; Prévost G; Subilia A; Gaucher D; Jehl F
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4832-41. PubMed ID: 22661478
[TBL] [Abstract][Full Text] [Related]
15. Intraocular pharmacokinetics of intravenously administered marbofloxacin in rabbits with experimentally induced acute endophthalmitis.
Regnier A; Schneider M; Concordet D; Toutain PL
Am J Vet Res; 2008 Mar; 69(3):410-5. PubMed ID: 18312141
[TBL] [Abstract][Full Text] [Related]
16. A preliminary study to treat severe endophthalmitis via a foldable capsular vitreous body with sustained levofloxacin release in rabbits.
Wang T; Huang X; Gao Q; Feng L; Xie Z; Jiang Z; Liu Y; Li Y; Lin X; Lin J
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):804-12. PubMed ID: 23258145
[TBL] [Abstract][Full Text] [Related]
17. Effects of trauma and infection on ciprofloxacin levels in the vitreous cavity.
Oztürk F; Kortunay S; Kurt E; Ilker SS; Inan UU; Basci NE; Bozkurt A; Kayaalp O
Retina; 1999; 19(2):127-30. PubMed ID: 10213238
[TBL] [Abstract][Full Text] [Related]
18. [Anti-infectious effect of sustained antravitreal amphotericin B drug delivery system on experimental rabbit fungal endophthalmitis of Candida albicans].
Chen N; Yang YT; Dong XG; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 May; 42(5):420-5. PubMed ID: 16762236
[TBL] [Abstract][Full Text] [Related]
19. Sustained release intravitreal dexamethasone.
Hainsworth DP; Pearson PA; Conklin JD; Ashton P
J Ocul Pharmacol Ther; 1996; 12(1):57-63. PubMed ID: 8925398
[TBL] [Abstract][Full Text] [Related]
20. Intravitreally implantable voriconazole delivery system for experimental fungal endophthalmitis.
Yang L; Dong X; Wu X; Xie L; Min X
Retina; 2011 Oct; 31(9):1791-800. PubMed ID: 21606889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
